businesspress24.com - Cromos(TM) Pharma Announces Participation in ASCO 2012 on June 1-5 in Chicago, IL
 

Cromos(TM) Pharma Announces Participation in ASCO 2012 on June 1-5 in Chicago, IL

ID: 1117555

(firmenpresse) - LONGVIEW, WA -- (Marketwire) -- 05/24/12 -- Cromos™ Pharma, a full service, regional Contract Research Organization (CRO), announced today that it will participate and exhibit at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL on June 1-5, 2012.

"ASCO annual meeting is a great venue for Western Pharma companies and CROs looking into expanding the geography of their clinical trial programs to meet solution providers such as our company," said Dr. Vladimir Bogin, CEO of Cromos™ Pharma. "Russia, Ukraine and other countries of Eastern Europe have become integral to the success of international studies and contribute greatly to their speed and quality," continued Dr. Bogin. "If you are not yet convinced of the need to add Eastern Europe to your trial locations, stop by Cromos™ Pharma's booth to help us change your mind."

Dr. Bogin, along with Dr. Andrey Tarakanov, head of the company's Russian office, and Dr. Vladimir Krechikov, Director for Business Development, will be available to answer your questions at booth # 5096, Zone B.

About Cromos™ Pharma

Cromos™ Pharma is a full service CRO and a sourcing vendor that prides itself on very high quality of work, full GCP compliance and some of the brightest minds in the business. It helps its clients navigate through all stages of clinical trial process -- starting from drafting of study protocol through regulatory support and all the way to final study report and statistical analysis. Cromos™ Pharma provides services to both foreign and domestic pharma since 2005 and is a privately owned company.



Contact information for Russia, Ukraine and countries of C&E Europe:
Vladimir Krechikov, MD, PhD
Director of Business Development
Tel: +7 495 748 02 37
Toll free (for calls within Russia only): 8 800 100 21 78
Fax: +7 495 748 02 38
Email:




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  RayBiotech, Inc. Establishes Master Services Agreement With Major Biopharmaceutical Company
Prana to Present at the UBS Australian Healthcare Conference in Sydney and the Australian Life Science Investment Showcase in New York
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 24.05.2012 - 00:00 Uhr
Sprache: Deutsch
News-ID 1117555
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LONGVIEW, WA


Phone:

Kategorie:

Trials


Anmerkungen:


Diese Pressemitteilung wurde bisher 228 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cromos(TM) Pharma Announces Participation in ASCO 2012 on June 1-5 in Chicago, IL
"
steht unter der journalistisch-redaktionellen Verantwortung von

Cromos Pharma (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cromos Pharma



 

Who is online

All members: 10 564
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 51


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.